---
schema_version: "secwatch.filing_event.v1"
accession: "0001437749-25-027270"
form_type: "8-K"
ticker: "VTAK"
cik: "0001716621"
company_name: "Catheter Precision, Inc."
filed_at: "2025-08-18T23:59:59+00:00"
generated_at: "2026-05-17T11:57:40.956461+00:00"
event_type: "regulatory"
sentiment: "positive"
materiality_score: 0.55
calibrated_materiality_score: 0.55
confidence: "high"
source: SEC EDGAR
---

# Catheter Precision secures UK approval for LockeT; partners with distributor HC21

## Summary
- LockeT suture retention device approved for commercialization in the UK; received CE Mark in May 2025.
- Exclusive distribution agreement with HC21 (€180M revenue, 500+ employees across UK and Ireland).
- LockeT aims to enhance patient comfort, enable earlier discharge, and help NHS reduce waiting lists.
- Fatih Ayoglu (Sales Manager EMEA & APAC) highlighted potential to free up hospital capacity and accelerate patient throughput.

## SEC filing metadata
- accession: 0001437749-25-027270
- form_type: 8-K
- ticker: VTAK
- cik: 0001716621
- company_name: Catheter Precision, Inc.
- filed_at: 2025-08-18T23:59:59+00:00
- event_type: regulatory
- sentiment: positive
- materiality_score: 0.55
- calibrated_materiality_score: 0.55
- confidence: high
- sec_items: 8.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1716621/000143774925027270/0001437749-25-027270-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1716621/000143774925027270/vtak20250818c_8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001437749-25-027270
- JSON: https://secwatch.observer/filing/0001437749-25-027270.json
- Plain text: https://secwatch.observer/filing/0001437749-25-027270.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.